Incomplete Response to Induction in Acute Myelogenous Leukemia and Salvage Approaches – pro

Standard Therapy of of acute myelogenous leukemia (excluding acute promyelocytic leukemia) begins with induction. Various acceptable induction regimens are available. The most common approach is called ”3 and 7,” which consists of 3 days of a 15- to 30-minute infusion of an anthracycline (idarubicin or daunorubicin) or anthracenedione (mitoxantrone), combined with 100 mg/m2 of arabinosylcytosine (araC) as a 24-hour infusion daily for 7 days.

Read more